{
    "2021-03-21": [
        [
            {
                "time": "",
                "original_text": "医药生物行业周报：基因细胞治疗CDMO黄金赛道有望孕育下一个药明生物",
                "features": {
                    "keywords": [
                        "医药生物",
                        "基因细胞治疗",
                        "CDMO",
                        "黄金赛道",
                        "药明生物"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "生物医药行业周报：新冠疫苗相继获批上市 密切关注一季度业绩",
                "features": {
                    "keywords": [
                        "生物医药",
                        "新冠疫苗",
                        "获批上市",
                        "一季度业绩"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "CXO行业无海外订单回流风险，龙头业绩向好 调整后估值优势凸显",
                "features": {
                    "keywords": [
                        "CXO",
                        "海外订单",
                        "回流风险",
                        "龙头业绩",
                        "估值优势"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}